Quest Diagnostics (DGX) Asset Writedowns and Impairment (2009 - 2019)

Quest Diagnostics has reported Asset Writedowns and Impairment for 11 years, with the latest figure at $2.0 million in Q4 2019.

• Quarterly Asset Writedowns and Impairment fell 50.0% year-over-year to $2.0 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $11.0 million (up 83.33% YoY) and the FY2024 annual result came in at $5.0 million, up 400.0% from the prior year.
• Asset Writedowns and Impairment slipped to $2.0 million in Q4 2019 per DGX's latest filing, from $4.0 million in the prior quarter.
• Over five years, Asset Writedowns and Impairment peaked at $86.0 million in Q1 2016 and troughed at -$235.0 million in Q4 2016.
• A 5-year average of $16.4 million and a median of $3.5 million in 2017 frame the typical range for Asset Writedowns and Impairment.
• The sharpest annual moves came in 2016 and 2019: Asset Writedowns and Impairment sank 461.54% in 2016, then surged 133.33% in 2019.
• Over 5 years, Asset Writedowns and Impairment stood at $65.0 million in 2015, then tumbled by 461.54% to -$235.0 million in 2016, then soared by 101.28% to $3.0 million in 2017, then jumped by 33.33% to $4.0 million in 2018, then slumped by 50.0% to $2.0 million in 2019.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $2.0 million, $4.0 million, and $1.0 million for Q4 2019, Q3 2019, and Q2 2019 respectively.